-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VGpsDbKVOumV8w4rVfew1xwdT9E9vCMu8okFZvoBcDTazOHT3C0cakScfEvQ/keZ y8N9D3oHKTjEmZzBXS3NWg== 0001179110-08-005591.txt : 20080311 0001179110-08-005591.hdr.sgml : 20080311 20080311160712 ACCESSION NUMBER: 0001179110-08-005591 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080307 FILED AS OF DATE: 20080311 DATE AS OF CHANGE: 20080311 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: 7814330771 MAIL ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 021942725 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PENNER HARRY JR CENTRAL INDEX KEY: 0001131148 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 08680704 BUSINESS ADDRESS: BUSINESS PHONE: 2037731450 MAIL ADDRESS: STREET 1: C/O GENAISSANCE PHARMACEUTICALS STREET 2: 5 SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 4 1 edgar.xml FORM 4 - X0202 4 2008-03-07 0 0000744218 AVANT IMMUNOTHERAPEUTICS INC AVAN 0001131148 PENNER HARRY JR 6 WHITE PINE LANE GUILFORD CT 06437 1 0 0 0 Non-Qualified Stock Option 47.25 2008-03-07 4 M 0 416 47.25 A 1999-05-12 2008-05-12 Common Stock 416 416 D Non-Qualified Stock Option 8.16 2008-03-07 4 A 0 17728 8.16 A 2009-03-07 2015-03-07 Common Stock 17728 17728 D The option was previously reported as covering 5,000 shares at an exercise price of $3.9375 per share, but was adjusted to reflect the one-for-twelve reverse stock split that occurred on March 7, 2008. This option was granted for 212,739 shares at an exercise price of $0.68 per share, but was adjusted to reflect the one-for-twelve reverse stock split that occurred on March 7, 2008. 95,000 options granted under the AVANT 1999 Stock option and Incentive plan were cancelled according to their terms for no consideration on March 7, 2008. 95,000 shares Harry H. Penner, Jr. 2008-03-11 -----END PRIVACY-ENHANCED MESSAGE-----